Biohaven Ltd. (BHVN) FY2026 Q3 Balance Sheet

Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

As of 2026-09-30

Balance Sheet

Swipe to see the full flow
Biohaven Ltd. (BHVN) FY2026 Q3 Balance SheetBalance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.Current liabilities$62.77 MNon-current liabilities$299.16 MLiabilities$361.92 MCurrent assets$191.51 MAssets$263.68 MShareholders' deficit−$98.25 MNon-current assets$72.16 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsMarketable securitiesPrepaid expensesOther current assetsOther non-current assetsIntangible assetsProperty and equipment, netGoodwillAccrued expenses and other current liabilitiesAccounts payableNotes payableNon-current operating lease liabilityOther non-current liabilitiesAccumulated deficitCommon shares, no par value; 200,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 151,055,160 and 132,775,113 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectivelyAdditional paid-in capitalAccumulated other comprehensive incomeCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesShareholders' deficitShareholders' deficitAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$49.23 MCurrent liabilitiesCurrent liabilities$62.77 MAccounts payableAccounts payable$13.53 MNotes payableNotes payable$264.29 MNon-current liabilitiesNon-current liabilities$299.16 MCash and cash equivalentsCash and cash equivalents$95.75 MLiabilitiesLiabilities$361.92 MNon-current operating lease liabilityNon-current operating lease liability$31.41 MCurrent assetsCurrent assets$191.51 MMarketable securitiesMarketable securities$65.37 MOther non-current liabilitiesOther non-current liabilities$3.46 MPrepaid expensesPrepaid expenses$27.57 MOther current assetsOther current assets$2.82 MAssetsAssets$263.68 MAccumulated deficitAccumulated deficit−$2.48 BShareholders' deficitShareholders' deficit−$98.25 MOther non-current assetsOther non-current assets$37.67 MNon-current assetsNon-current assets$72.16 MIntangible assetsIntangible assets$18.40 MProperty and equipment, netProperty and equipment, net$14.70 MCommon shares, no par value; 200,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 151,055,160 and 132,775,113 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectivelyCommon shares, no par value$2.14 BGoodwillGoodwill$1.39 MAdditional paid-in capitalAdditional paid-in capital$238.84 MAccumulated other comprehensive incomeAccumulated other comprehensive income$5.35 M
Chart details

Biohaven Ltd. (BHVN) FY2026 Q3 Balance Sheet

Balance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.

Assets
263,676,000 US dollars
Current assets
191,514,000 US dollars
Non-current assets
72,162,000 US dollars
Liabilities
361,923,000 US dollars
Current liabilities
62,767,000 US dollars
Non-current liabilities
299,156,000 US dollars
Shareholders' deficit
negative 98,247,000 US dollars
Cash and cash equivalents
95,754,000 US dollars
Marketable securities
65,371,000 US dollars
Prepaid expenses
27,566,000 US dollars
Other current assets
2,823,000 US dollars
Other non-current assets
37,672,000 US dollars
Intangible assets
18,400,000 US dollars
Property and equipment, net
14,700,000 US dollars
Goodwill
1,390,000 US dollars
Accrued expenses and other current liabilities
49,233,000 US dollars
Accounts payable
13,534,000 US dollars
Notes payable
264,294,000 US dollars
Non-current operating lease liability
31,406,000 US dollars
Other non-current liabilities
3,456,000 US dollars
Common shares, no par value; 200,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 151,055,160 and 132,775,113 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively
2,139,226,000 US dollars
Additional paid-in capital
238,835,000 US dollars
Accumulated other comprehensive income
5,350,000 US dollars
Preferred shares, no par value; 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2026 and December 31, 2025
0 US dollars
Accumulated deficit
negative 2,481,658,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Biohaven Ltd. (BHVN) FY2026 Q3 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!